Insulin aspart - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
RYZODEG 70/30 FLEXTOUCH 70% insulin degludec (rys) / 30% insulin aspart (rys) 100 U/mL solution for injection cartridge AUST R: 280432Active ingredients:
Insulin aspart
Insulin degludec
Dosage form:
Injection, solution
Sponsor:
Novo Nordisk Pharmaceuticals Pty Ltd
Phone:
1800 668 626
|
Deletion from market:
01 Feb 2025
|
Shortage status:
To be discontinued
Availability:
Reduction in supply until supply is exhausted
Reason:
Commercial Changes / Commercial viability
Management action:
An alternative presentation is available.
|